It's an unsettling journey -- the pursuit of the five-year cancer survival mark. Some say each year of cancer survival makes the future more of a sure thing. And so surviving five years -- the traditional landmark of real remission -- is a big accomplishment. But then there's the perspective of numbers that for me say I have a 93 percent chance of surviving breast cancer for five years. After that, though, there's no telling what will happen. So I am eagerly awaiting the moment when I cross the five-year finish line as I anxiously realize this very same moment may also signal a more dismal outlook.

The paradox hit me straight in the face yesterday as I was waiting for my radiation oncologist to give me another six-month all clear announcement. I was reading the January/February 2007 issue of Coping magazine while I waited. And as I flipped through the pages, I landed right at these words:

Studies show that half of all breast cancer recurrences occur after completion of five years of standard tamoxifen therapy. Additionally, a third of women with estrogen receptor-positive early breast cancer experience a recurrence, and more of half of these recurrences occur more than five years after surgery.

Now this doesn't apply directly to me. My breast cancer was estrogen receptor-negative which makes me a non-candidate for tamoxifen. And this is what scares me. My tumor was aggressive and while my treatment was also aggressive, I don't get the extra five-year protection from hormone therapy. If women taking this drug can have recurrences after completing the therapy, I wonder what's in store for me having not had it.

Maybe I'm making comparisons that don't amount to any real conclusions. Perhaps my type of disease allows for a more secure future. Or perhaps it places me on shaky ground. I don't know for sure. And I don't think I'll dive any deeper into research than I already have. Instead, I will live for today -- while enjoying the announcement my oncologist shared with me yesterday. All clear!

An announcement last Wednesday revealed an overall decline in cancer death rates -- probably due to reduced exposure to tobacco, early detection, and better treatment. But the announcement also revealed a surprising jump in cases of thyroid cancer for women.

Between the years 1981 and 1993, incidence rates among women climbed 2.2 percent each year. Between the years 1993 and 2000, they rose 4.6 percent per year. And between 2000 and 2003, there was a 9.1 percent increase each year. This could be a result of better diagnosis but scientists are wondering if there is an unknown risk factor contributing to this startling finding. And it will take at least two more years to determine whether this is a random fluctuation or a true trend. The rate of thyroid cancer in men has also increased but not as much as for women.

The silver lining in this cancer cloud is that trends -- such as those showing increases in cancer incidences and death rates -- often fuel the fight against cancer because researchers are alerted to look for causes which ultimately results in better detection and better prevention.

The world is a dangerous place for the trusting and the innocent -- which is probably one of the reasons we have some of the laws we do to protect everyone.

Still, even with laws in place, it seems we are not all that safe. Frankly, I am disturbed by what I learned that I did not know about prescription drugs being dispensed in this country and the estimated number of those prescriptions that are counterfeit drugs. Drugs of ineffective strength. Drugs made with unknown chemicals. Drugs switched with less expensive drugs meant for another medical condition. Basically -- the wrong drugs.